Freedom from Structural Valve Deterioration

Author Year No. of
Patients		 Type of
Study		 Type of
Valve		 Mean
Follow-Up (yrs)		 5 years
(%)		 10 years
(%)		 15 years
(%)		 20 years
(%)		 25 years
(%)		 Linearized rate
(% per pt year)
Butchart et al, 2001 796 Prospective Follow-Up Medtronic Hall 7.6 - 100 100 - - 0
Khan et al, 2001 513 Prospective Follow-Up St. Jude Medical * 100 100 100 - - 0
Remadi et al, 2001 440 Retrospective St. Jude Medical 19 - - - 100% (19yr) - 0
Murday et al, 2003 61 Prospective Randomized Trial St. Jude Medical 8 - - - - - -
Borman et al, 2003 656 Retrospective Multicenter Sorin Bicarbon 4.6 - 100 (8yr) - - - 0
Tominaga et al, 2005 253 Prospective Follow-Up Carbomedics 5.1 - 100 - - - 0
Baykut et al, 2006 168 Retrospective ATS 4.3 100 100 - - - 0
Wu et al, 2006 196 Prospective Follow-Up Carbomedics 4.6 - - - - - -
Aoyagi et al, 2007 115 Retrospective ATS 4.2 100 100 (7yr) - - - 0
Bryan et al, 2007 75 Prospective Randomized Trial Carbomedics 10 100 100 - - - 0
Bryan et al, 2007 85 Prospective Randomized Trial St. Jude Medical 10 100 100 - - - 0
Spiliopoulos et al, 2009 122 Prospective Follow-Up Sorin Bicarbon 9.8 100 100 - - - 0
Azarnoush et al, 2010 586 Prospective Follow-Up Sorin Bicarbon 10.2 100 100 100 - - 0
Toole et al, 2010 408 Prospective Follow-Up St. Jude Medical Standard, Masters, HP, and Regent 9 100 100 100 100 100 0
Aaron J. Weiss M.D., Stephen M. Spindel M.D., and Farzan Filsoufi M.D.
* No mean follow-up provided. Total follow up was 13,390 years
  1. Butchart EG, Li HH, Payne N, et al. Twenty years' experience with the Medtronic Hall valve. J Thorac Cardiovasc Surg 2001;121:1090-100.
  2. Khan SS, Trento A, DeRobertis M, et al. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 2001;122:257-69.
  3. Remadi JP, Baron O, Roussel C, et al. Isolated mitral valve replacement with St. Jude medical prosthesis: long-term results: a follow-up of 19 years. Circulation 2001;103:1542-5.
  4. Murday AJ, Hochstitzky A, Mansfield J, et al. A prospective controlled trial of St. Jude versus Starr Edwards aortic and mitral valve prostheses. Ann Thorac Surg 2003;76:66-73; discussion 73-4.
  5. Borman JB, De Riberolles C. Sorin Bicarbon bileaflet valve: a 10-year experience. Eur J Cardiothorac Surg 2003;23:86-92.
  6. Tominaga R, Kurisu K, Ochiai Y, et al. A 10-year experience with the Carbomedics cardiac prosthesis. Ann Thorac Surg 2005;79:784-9.
  7. Baykut D, Grize L, Schindler C, et al. Eleven-year single-center experience with the ATS Open Pivot Bileaflet heart valve. Ann Thorac Surg 2006;82:847-52.
  8. Wu Y, Gao G, Mody S, et al. Update of the Providence Health System experience with the CarboMedics prosthesis. J Heart Valve Dis 2006;15:414-20.
  9. Aoyagi S, Hori H, Yoshikawa K, et al. Mid-term results of valve replacement with the ATS valve: a seven-year follow up. J Heart Valve Dis 2007;16:267-74.
  10. Bryan AJ, Rogers CA, Bayliss K, et al. Prospective randomized comparison of CarboMedics and St. Jude Medical bileaflet mechanical heart valve prostheses: ten-year follow-up. J Thorac Cardiovasc Surg 2007;133:614-22.
  11. Spiliopoulos K, Haschemi A, Parasiris P, et al. Sorin Bicarbon bileaflet valve: a 9.8-year experience. Clinical performance of the prosthesis after heart valve replacement in 587 patients. Interact Cardiovasc Thorac Surg 2009;8:252-9.
  12. Azarnoush K, Laborde F, de Riberolles C. The Sorin Bicarbon over 15 years clinical outcomes: multicentre experience in 1704 patients. Eur J Cardiothorac Surg 2010;38:759-66.
  13. Toole JM, Stroud MR, Kratz JM, et al. Twenty-five year experience with the St. Jude medical mechanical valve prosthesis. Ann Thorac Surg 2010;89:1402-9.